Investing Profile

Kevin Koch

InvestorVC
Venture Partner at OrbiMed
orbimed.comBoulder, Colorado
Photo of Kevin Koch, Venture Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Pfizer Network
86 CONNECTIONS
Pfizer Network
86 CONNECTIONS
Pfizer Network
86 CONNECTIONS
Pfizer Network
86 CONNECTIONS
Amgen Network
42 CONNECTIONS
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
3
$18B
CompanyStageDateRound SizeTotal Raised
Terremoto Biosciences
Series CApr 2026$110M
Series BNov 2023$180M
Series AMay 2022$75M
$360M
Co-investors: Reid Huber (Third Rock Ventures), Peter Thompson (OrbiMed Advisors), Jeffrey Tong (Third Rock Ventures)
President and Chief Scientific Officer Array BioPharma Inc.Present
Co-Founder Array BioPharma Array BioPharma Inc.Present
Associate Scientist, Process Research CibaPresent
Research Scientist PfizerPresent
Inventor PfizerPresent
Senior Research Scientist PfizerPresent
Senior Research Investigator PfizerPresent
Associate Director, Medicinal Chemistry AmgenPresent
Senior Vice President, Drug Discovery, Chemical & Molecular Therapeutics BiogenPresent
President and Chief Scientific Officer, Company Founder Array BioPharma Inc.Present
Venture Partner OrbiMedPresent
President and CEO Edgewise TherapeuticsPresent
Stony Brook University M.S B.S., Chemistry & Biochemistry
University of Rochester, Dept. of Chemistry B.S. M.S, Organic Chemistry, May 1986
Stony Brook University B.S. Chemistry & Biochemistry
State University of New York, Stony Brook B.S. Chemistry & Biochemistry
University of Rochester, Dept. of Chemistry M.S Organic Chemistry, May 1986
University of Rochester, Dept. of Chemistry Ph.D. Synthetic Organic Chemistry, 1988
University of Rochester, Dept. of Chemistry Ph.D. Synthetic Organic Chemistry,1988
Sign in with Google →
Sign in with Google →